AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

AGM Information Nov 13, 2019

7581_dva_2019-11-13_79cd02f5-fff4-497e-9134-7ced800ddaad.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3280T

Craneware plc

13 November 2019

Craneware plc

Result of AGM

13 November 2019 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held yesterday, all resolutions were duly passed.

Following the close of the meeting, Ron Verni, Non-executive Director, has temporarily taken the role of Interim Chairman until Will Whitehorn assumes the role of Chairman of the Board on 1 January 2020, as described in the AGM Statement released yesterday.

The proxy voting results are included below.  

Resolution For Against Discretion to Chairman and Third party Withheld Total
01 17,146,910 0 0 7,211 17,154,121
02 16,557,831 595,563 0 727 17,154,121
03 12,434,608 4,601,250 0 118,263 17,154,121
04 17,119,616 33,979 0 526 17,154,121
05 17,117,165 36,430 0 526 17,154,121
06 13,139,798 4,013,797 0 526 17,154,121
07 17,122,584 31,011 0 526 17,154,121
08 17,153,595 0 0 526 17,154,121
09 12,276,731 4,876,663 0 727 17,154,121
10 16,153,986 998,429 1,180 526 17,154,121
11 17,147,775 5,820 0 526 17,154,121
12 16,056,496 1,097,099 0 526 17,154,121
13 16,950,177 200,450 0 3,494 17,154,121

Resolutions 3, 6 and 9

The Board of Directors notes that while Resolutions 3, 6 and 9 were passed and a majority of over 71% of the proxy votes received were 'for' each of these resolutions, a number of the proxy votes received opposed these resolutions.

We will consult with our shareholders in order to understand more fully the reasons for their votes in regard to these resolutions and we will reflect carefully on feedback received from our shareholders.

An update on the consultation process will be made, in accordance with the UK Corporate Governance Code, within six months of the AGM.

For further information, please contact:

Craneware plc Peel Hunt (NOMAD & Joint Broker) Investec Bank (Joint Broker) Alma (Financial PR)
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)20 7597 5970 +44 (0)203 405 0205
Keith Neilson, CEO Dan Webster Patrick Robb Caroline Forde
Craig Preston, CFO George Sellar Sebastian Lawrence Hilary Buchanan
Guy Pengelley Henry Reast Helena Bogle

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RAGBLBDBLGBBGCX

Talk to a Data Expert

Have a question? We'll get back to you promptly.